Works matching T-cell lymphoma


Results: 5000
    1
    2
    3
    4

    Evaluation of the PIK3 pathway in peripheral T‐cell lymphoma and NK/T‐cell lymphoma.

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 4, p. 731, doi. 10.1111/bjh.16435
    By:
    • Huang, Dachuan;
    • Song, Tammy Linlin;
    • Nairismägi, Maarja‐Liisa;
    • Laurensia, Yurike;
    • Pang, Wan‐Lu;
    • Zhe, Daryl Cheah Ming;
    • Wong, Esther Kam Yin;
    • Wijaya, Giovani Giovani‐Clarest;
    • Tan, Jing;
    • Tan, Sze Huey;
    • Lim, Jing‐Quan;
    • Chia, Burton Kuan Hui;
    • Chan, Jason Yongsheng;
    • Tang, Tiffany Pooi Ling;
    • Somasundaram, Nagavalli;
    • Cheng, Chee Leong;
    • Politz, Oliver;
    • Liu, Ningshu;
    • Lim, Soon Thye;
    • Ong, Choon Kiat
    Publication type:
    Article
    5
    6
    7

    Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the national hospital organization in Japan.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 4, p. 819, doi. 10.1080/10428194.2020.1845336
    By:
    • Yamasaki, Satoshi;
    • Iida, Hiroatsu;
    • Yoshida, Isao;
    • Komeno, Takuya;
    • Sawamura, Morio;
    • Matsumoto, Morio;
    • Sekiguchi, Naoshiro;
    • Hishita, Terutoshi;
    • Sunami, Kazutaka;
    • Shimomura, Takeshi;
    • Takatsuki, Hiroshi;
    • Yoshida, Shinichiro;
    • Otsuka, Maki;
    • Kato, Takeharu;
    • Kuroda, Yoshiaki;
    • Ooyama, Tadashi;
    • Suzuki, Yasuhiro;
    • Ohshima, Koichi;
    • Nagai, Hirokazu;
    • Iwasaki, Hiromi
    Publication type:
    Article
    8

    Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 330, doi. 10.1080/10428194.2020.1827241
    By:
    • Bhurani, Mansi;
    • Admojo, Lorenz;
    • Van Der Weyden, Carrie;
    • Twigger, Robert;
    • Bazargan, Ali;
    • Quach, Hang;
    • Zimet, Allan;
    • Coyle, Luke;
    • Lindsay, Julian;
    • Radeski, Dejan;
    • Hawkes, Eliza;
    • Kennedy, Glen;
    • Irving, Ian;
    • Gutta, Naadir;
    • Trotman, Judith;
    • Yeung, James;
    • Dunlop, Lindsay;
    • Hua, Minh;
    • Giri, Pratyush;
    • Yuen, Sam
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Peripheral T‐cell lymphoma with a T follicular‐helper phenotype: A different entity? Results of the Spanish Real‐T study.

    Published in:
    British Journal of Haematology, 2023, v. 203, n. 2, p. 182, doi. 10.1111/bjh.18941
    By:
    • Martín García‐Sancho, Alejandro;
    • Rodríguez‐Pinilla, Socorro M.;
    • Domingo‐Domenech, Eva;
    • Climent, Fina;
    • Sánchez‐Garcia, Joaquín;
    • López Jiménez, Javier;
    • García‐Cosío Piqueras, Mónica;
    • Castellvi, Josep;
    • González, Ana Julia;
    • González de Villambrosia, Sonia;
    • Gómez Codina, José;
    • Navarro, Belén;
    • Rodríguez, Guillermo;
    • Borrero, Juan José;
    • Fraga, Máximo;
    • Naves, Andrea;
    • Baeza, Lourdes;
    • Córdoba, Raúl
    Publication type:
    Article
    15
    16
    17
    18

    The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.

    Published in:
    British Journal of Haematology, 2017, v. 176, n. 5, p. 750, doi. 10.1111/bjh.14477
    By:
    • Chihara, Dai;
    • Fanale, Michelle A.;
    • Miranda, Roberto N.;
    • Noorani, Mansoor;
    • Westin, Jason R.;
    • Nastoupil, Loretta J.;
    • Hagemeister, Fredrick B.;
    • Fayad, Luis E.;
    • Romaguera, Jorge E.;
    • Samaniego, Felipe;
    • Turturro, Francesco;
    • Lee, Hun J.;
    • Neelapu, Sattva S.;
    • Rodriguez, M. Alma;
    • Wang, Michael;
    • Fowler, Nathan H.;
    • Davis, Richard E.;
    • Medeiros, L. Jeffrey;
    • Hosing, Chitra;
    • Nieto, Yago L.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41

    Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 9, p. 2592, doi. 10.3109/10428194.2014.1001985
    By:
    • Shiratori, Souichi;
    • Kosugi-Kanaya, Mizuha;
    • Shigematsu, Akio;
    • Kobayashi, Hajime;
    • Yamamoto, Satoshi;
    • Kobayashi, Naoki;
    • Iwasaki, Hiroshi;
    • Mori, Akio;
    • Kunieda, Yasuyuki;
    • Yutaka, Tsutsumi;
    • Kurosawa, Mitsutoshi;
    • Kakinoki, Yasutaka;
    • Endo, Tomoyuki;
    • Kondo, Takeshi;
    • Hashino, Satoshi;
    • Teshima, Takanori
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50